Cardlytics Q3 2023 Earnings Presentation
19
Reconciliation of GAAP net
(loss) income to adjusted EBITDA
Net (loss) income
Plus:
Income tax benefit
Interest expense, net
Depreciation and amortization expense
Stock-based compensation expense
Foreign currency (gain) loss
Deferred implementation costs
Acquisition and integration costs (benefit)
(Gain) loss in fair value of contingent consideration
Impairment of goodwill and intangible assets
Restructuring and reduction of force
Adjusted EBITDA
Mar 31,
2021
($24,895)
3,045
3,065
7,248
(319)
882
7,030
Jun 30,
2021
($47,306)
3,078
8,833
13,337
730
14,182
1,480
($3,944) ($5,666)
Sept 30,
2021
($44,529)
3,193
8,375
16,830
1,543
731
1,714
6,261
713
($5,169)
Dec 31,
2021
($11,834)
(7,864)
3,247
9,598
12,849
43
1,442
1,446
(6,367)
Mar 31,
2022
$33,038
947
9,871
13,585
1,671
(4,599)
(65,050)
Three Months Ended
Jun 30,
2022
($126,290)
(1,446)
879
10,356
12,842
4,538
2,197
(2,968)
83,149
Sept 30,
2022
958
$6,267
580
10,468
5,767
4,673
(1,867)
(46,126)
Dec 31,
2022
($378,279)
150
6,849
12,492
(4,506)
(14,030)
370,139
7,530
(347)
$2,560 ($10,537) ($15,785) ($12,708) ($6,137)
1,395
Mar 31,
2023
$13,608
8
6,575
7,968
(1,389)
1,723
(34,584)
(Amounts in thousands)
Jun 30,
2023
($23,508)
574
7,200
11,739
(1,389)
(9,947)
11,258
($6,091) ($4,073)
Sept 30,
2023
($23,966)
915
5,990
10,249
2,399
78
8,281
$3,946View entire presentation